UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY)

Q: What does CUSIP 90466Y103 represent in this 13F holders report?

CUSIP 90466Y103 is the security identifier for UNCY - UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held UNCY - UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share in Q4 2021?

9 institutional investors reported UNCY - UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share for Q4 2021. Use the holders table for investor-level position and value details.

CUSIP: 90466Y103

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 18,578,488
Total 13F shares: 1,115,406
Share change: -26,884
Total reported value: $2,298,000
Price per share: $2.06
Number of holders: 9
Value change: -$90,197
Number of buys: 3
Number of sells: 4

Quarterly Holders Quick Answers

What is CUSIP 90466Y103?
CUSIP 90466Y103 identifies UNCY - UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2022
Previous quarter: Q3 2021

Recent filing periods for CUSIP 90466Y103:

Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023

Top shareholders of UNCY - UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Nantahala Capital Management, LLC	13F	Company	3.8%	700,000	$1,981,000	—	30 Sep 2021	13F
Board of Trustees of The Leland Stanford Junior University	13F	Company	1.3%	247,583	$700,000	—	30 Sep 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.14%	26,109	$73,000	—	30 Sep 2021	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.14%	25,551	$72,000	—	30 Sep 2021	13F
SANDERS MORRIS HARRIS LLC	13F	Company	0.11%	20,000	$57,000	—	30 Sep 2021	13F
Frontier Wealth Management LLC	13F	Company	0.1%	18,838	$53,000	—	30 Sep 2021	13F
TANDEM CAPITAL MANAGEMENT CORP /ADV	13F	Company	0.08%	15,500	$44,000	—	30 Sep 2021	13F
BlackRock Finance, Inc.	13F	Company	0.06%	11,443	$33,000	—	30 Sep 2021	13F
UBS Group AG	13F	Company	0%	621	$2,000	—	30 Sep 2021	13F

Institutional Holders of UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) as of Q4 2021

As of 31 Dec 2021, UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) was held by 9 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,115,406 shares. The largest 9 holders included Nantahala Capital Management, LLC, Board of Trustees of The Leland Stanford Junior University, Ayrton Capital LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, Frontier Wealth Management LLC, BlackRock Inc., TANDEM CAPITAL MANAGEMENT CORP /ADV, and UBS Group AG. This page lists 9 institutional shareholders reporting positions in this security for the Q4 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders

Q4 2021 holders

Holder diff

Investor	Q3 2021 Shares	Q4 2021 Shares	Share Diff	Share Chg %	Q3 2021 Value $	Q4 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.